Have you, a family member, or dear friend been diagnosed with diabetes, diabetic ketoacidosis, hyperglycemia, pancreatitis, or diabetic-induced heart attack or coma following use of Zyprexa? You may want to consider Zyprexa litigation and may want to consult with a lawyer familiar with Zyprexa litigation. If so, please complete FREE no obligation consultation today.

Researchers have linked Zyprexa to side-effect of onset of diabetes, hyperglycemia, and neuroleptic malignant syndrome thereby creating enough concern and patient outcry to lead Japan, Europe, and most recently United States to include warnings about chronic side-effects and sometimes-fatal Zyprexa side-effect. (Japan published safety warnings two years before U.S.) Consumer groups believe that FDA had done too little too late to warn doctors and patients about risks of hyperglycemia, diabetes, ketoacidosis, heart attack, and coma from taking Zyprexa.

In November 2001, Journal of American Medical Association, FDA's Center for Drug Evaluation and Research, and a Duke University Medical Center physician first possibly linked between Zyprexa side-effect of hyperglycemia in adolescents with drug. FDA staff members published a report in December 2001 American Journal of Medicine linking Zyprexa to diabetes. Both Zyprexa reports used information from FDA's adverse drug reaction database.